|
Status |
Public on Sep 14, 2023 |
Title |
Lysine methylation of EHMT1/GLP as a molecular switch to reprogram transcription networks in prostate cancer [RNA-seq UNC0642] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Our studies provide novel molecular insights into the activity and function of EHMT1 during PCa progression and suggest a novel therapeutic strategy to treat CRPC with EHMT1 inhibitors.
|
|
|
Overall design |
LNCaP-tet-EHMT1 cells were treated with/out 0.5ug/mL docxycycline and 2uM UNC0642 for two days. LNCaP cells were treated with siNTC, SiEHMT2 at 20nM for two days. All RNA-seq samples contain replications.
|
|
|
Contributor(s) |
Besschetnova A, Han W, Liu M, Han D, Cai C |
Citation(s) |
37663929 |
Submission date |
Feb 10, 2023 |
Last update date |
Sep 14, 2023 |
Contact name |
Changmeng Cai |
E-mail(s) |
changmeng.cai@umb.edu
|
Organization name |
University of Massachusetts Boston
|
Street address |
100 William T Morrissey Blvd
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02125 |
Country |
USA |
|
|
Platforms (1) |
|
Samples (10)
|
|
This SubSeries is part of SuperSeries: |
GSE201771 |
Lysine methylation of EHMT1/GLP as a molecular switch to reprogram transcription networks in prostate cancer |
|
Relations |
BioProject |
PRJNA933650 |